Navigation Links
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
Date:5/7/2009

Hyperemia in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

Authors: J.A. Gow, G.L. Torkildsen, J.I. Williams, P.J. Gomes, M.B. Abelson, T.R. McNamara

Bromfenac for the Treatment of Chronic Pseudophakic Cystoid Macular Edema

Author: E.F. Kadrmas

Stability of Vitrase(R) Solutions after Dilution in Anesthetics

Authors: B.A. Aird, J.D. Dahlstrom, G.A. Baklayan, J.A. Gow

Abstracts are available on the ARVO website at http://www.arvo.org.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $5.1 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , October 17, 2014 ... report "Optical Imaging Market by Technique (Optical Coherence ... Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) ... MarketsandMarkets, this report studies the Optical Imaging market ... market was valued at $917.1 million in ...
(Date:10/17/2014)... BALTIMORE, Md. , Oct. 17, 2014 /PRNewswire-USNewswire/ ... Center for Medical Technology Policy: The ... from the FDA, public and private payers, medical ... representatives, clinicians, and other experts January 12, 2015 ... effectiveness and value of weight loss treatments.  Participants ...
(Date:10/17/2014)... Oct. 17, 2014  Ameritox SM , the nation,s ... of Thomas Smith , M.D., as Chief Medical ... team offering scientific resources for healthcare providers, patients and ... leadership positions at a variety of healthcare companies that ... the pain and behavioral health sides of Ameritox,s business. ...
Breaking Medicine Technology:Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2Ameritox Appoints New Chief Medical Officer 2
(Date:10/20/2014)... October 20, 2014 Principle Business Enterprises, ... pride in manufacturing top-of-the-line absorbent products. The company ... its most popular brand, Tranquility® Premium Protection absorbent products. ... new website, gave its packaging a new look, and ... brand message to the public. , The new website, ...
(Date:10/20/2014)... Succeed is proud to announce that they ... in the Every Body Walk! campaign by Kaiser ... that encourages workers to be more active outside of the ... concluded at the end of September, was a friendly competition ... areas. Participating companies gave their staff pedometers and each ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The ... member hospital ROI on membership dues at 12.5. In other ... $12.50 in value to member hospitals. The calculation used to ... Dues. , “This is the first time we’ve actually ... the methodology is really sound,” said Bill Ryan , ...
(Date:10/20/2014)... 2014 Do you ever feel difficulty ... a wonderful app Metassessor for teachers, specialists and parents. ... helped its client “Intervention Development LLC” to launch Metassessor ... designed for iOS 4.3 or later and is Compatible ... optimized for iPhone 5. It is now available on ...
(Date:10/19/2014)... 2014 Dr. Babatunde Osotimehin, Executive Director ... of a ceasefire agreement that is expected to lead ... who were kidnapped from the north-eastern Nigerian town of ... long enough, and it is high time they are ... Osotimehin. , "We owe it to these girls to ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... , - New Hayfever Relief Product ... on the Internet , - With Photo ... years ago, however, it,s believed that,it now affects as many as ... suffer,with hayfever, it,s either complete misery with symptoms such as reduced,concentration, ...
... likely than men to feel the pinch of rising ... (52%) of working-age women reporting problems accessing needed care ... a new Commonwealth Fund study finds. Women who are ... percent of underinsured women have problems accessing care because ...
... single protein prevents early damage in blood vessels from ... to research published online today in the journal ... signaling protein called cyclophilin A (CypA) from a strain ... against abdominal aortic aneurysm (AAA). , The aorta ...
... state man had underlying health problems, officials say , , ... in his 30s from Snohomish County, Wash., is the third ... state health officials said late Saturday. , In a Department ... an underlying heart condition, died last week with what appear ...
... to Support the Nancy Davis Foundation for Multiple Sclerosis ... of the world,s most exclusive super sport cars, donated ... Spyder to support the Nancy Davis Foundation for Multiple ... MS charity event at the Hyatt Regency Century Plaza ...
... alcohol are more likely to choose quick rewards , , ... a risk factor for alcoholism, a new study finds. ... bred to crave large amounts of alcohol were more ... The rodents, impulsivity was tested by giving them the ...
Cached Medicine News:Health News:'Qu-Chi' Acupressure Band Gives Hayfever Misery the Elbow 2Health News:'Qu-Chi' Acupressure Band Gives Hayfever Misery the Elbow 3Health News:7 of 10 women are uninsured or underinsured, or have medical bill, debt, access problems 2Health News:7 of 10 women are uninsured or underinsured, or have medical bill, debt, access problems 3Health News:Study in Nature Medicine establishes major new treatment target in diseased arteries 2Health News:Study in Nature Medicine establishes major new treatment target in diseased arteries 3Health News:Study in Nature Medicine establishes major new treatment target in diseased arteries 4Health News:Third U.S. Swine Flu Death Reported 2Health News:Third U.S. Swine Flu Death Reported 3Health News:Third U.S. Swine Flu Death Reported 4Health News:Third U.S. Swine Flu Death Reported 5Health News:Third U.S. Swine Flu Death Reported 6Health News:Third U.S. Swine Flu Death Reported 7Health News:Third U.S. Swine Flu Death Reported 8Health News:Third U.S. Swine Flu Death Reported 9Health News:Third U.S. Swine Flu Death Reported 10Health News:Third U.S. Swine Flu Death Reported 11Health News:First U.S. Lamborghini Gallardo LP 560-4 Spyder Auctioned at Race to Erase MS Charity Event 2Health News:Impulsivity Raises Alcoholism Risk 2
... The CA-1000 counts a Petri dish ... on the optical characteristics of the colonies ... The CA-1000 is equipped with three types ... are lighter or darker than the agar ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... Rapidpoint 400 is a sophisticated whole blood ... point-of-care testing while also satisfying the stringent ... multiple-use measurement cartridge contains all of the ... long-lasting cartridge includes the sampling unit, all ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: